Epigenetics is challenging long-held notions that our genes are our destiny and radically changing the way researchers think about the development of certain illnesses. As science come to understand the way epigenetic processes silence genes, it is given rise to promising new therapies for diseases such as MDS. Watch The Journal of Life Sciences webcast featuring

ALLEN YANG, MD, PhD
Assistant Professor, Hematology
USC / Norris Comprehensive Cancer Center
Keck School of Medicine

ANDREW ALLEN, BM, BCh, MA, MRCP, PhD
Executive Vice President and
Chief Medical Officer
Pharmion Corporation

KATHY HEPTINSTALL, BSN, RN
Operating Director
The MDS Foundation

This webcast was made possible through underwriting from Pharmion. 

Click here to view.